Core Viewpoint - The stock of Kefu Medical (301087) has shown stable performance with a closing price of 43.55 yuan as of October 29, 2025, with a slight increase in trading volume and mixed capital flow data indicating varying investor interest [1][2]. Group 1: Stock Performance and Capital Flow - As of October 29, 2025, Kefu Medical's stock closed at 43.55 yuan, with a trading volume of 24,100 hands and a total transaction amount of 104 million yuan [1]. - On October 29, the net outflow of main funds was 2.18%, while retail investors experienced a net outflow of 10.87%. Conversely, speculative funds saw a net inflow of 13.05% [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable net inflows and outflows from different investor categories [2]. Group 2: Financial Performance and Industry Comparison - Kefu Medical reported a total market value of 9.097 billion yuan, with a net asset value of 4.75 billion yuan and a net profit of 260 million yuan [3]. - The company achieved a year-on-year revenue increase of 6.63% in the first three quarters of 2025, with a significant 30.72% increase in the third quarter alone [3]. - Key financial metrics include a price-to-earnings ratio of 26.22, a price-to-book ratio of 1.93, and a gross margin of 53.35%, which is higher than the industry average [3]. Group 3: Analyst Ratings - In the last 90 days, seven institutions have issued buy ratings for Kefu Medical, indicating positive sentiment among analysts [4].
股票行情快报：可孚医疗（301087）10月29日主力资金净卖出227.10万元